Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms

키워드

참고문헌 (81)

1. Navi BB, "Ischemic stroke in cancer patients : a review of an underappreciated pathology", Ann Neurol, 83, pp.873~883 (2018)
2. Adams HP Jr, "Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment", Stroke, 24, pp.35~41 (1993)
3. Ay H, "An evidence-based causative classification system for acute ischemic stroke", Ann Neurol, 58, pp.688~697 (2005)
4. Amarenco P, "New approach to stroke subtyping : the A-SC-O(phenotypic)classification of stroke", Cerebrovasc Dis, 27, pp.502~508 (2009)
5. Marnane M, "Stroke subtype classification to mechanismspecific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study", Stroke, 41, pp.1579~1586 (2010)
6. Zöller B, "Risk of haemorrhagic and ischaemic stroke in patients with cancer : a nationwide follow-up study from Sweden", Eur J Cancer, 48, pp.1875~1883 (2012)
7. Erichsen R, "Risk of colorectal cancer in patients with acute myocardial infarction and stroke : a nationwide cohort study", Cancer Epidemiol Biomarkers Prev, 22, pp.1994~1999 (2013)
8. Chen PC, "Lung cancer and incidence of stroke : a population-based cohort study", Stroke, 42, pp.3034~3039 (2011)
9. Jang HS, "The long-term effect of cancer on incident stroke : a nationwide population-based cohort study in Korea", Front Neurol, 10, pp.52~ (2019)
10. Navi BB, "Association between incident cancer and subsequent stroke", Ann Neurol, 77, pp.291~300 (2015)
11. Navi BB, "Risk of arterial thromboembolism in patients with cancer", J Am Coll Cardiol, 70, pp.926~938 (2017)
12. Navi BB, "Arterial thromboembolic events preceding the diagnosis of cancer in older persons", Blood, 133, pp.781~789 (2019)
13. Kim SG, "Ischemic stroke in cancer patients with and without conventional mechanisms : a multicenter study in Korea", Stroke, 41, pp.798~801 (2010)
14. Sanossian N, "Trends in cancer diagnoses among inpatients hospitalized with stroke", J Stroke Cerebrovasc Dis, 22, pp.1146~1150 (2013)
15. Selvik HA, "Prior cancer in patients with ischemic stroke : the Bergen NORSTROKE study", J Stroke Cerebrovasc Dis, 23, pp.919~925 (2014)
16. Kim SJ, "Clues to occult cancer in patients with ischemic stroke", PLoS One, 7, pp.e44959~ (2012)
17. Cocho D, "Predictors of occult cancer in acute ischemic stroke patients", J Stroke Cerebrovasc Dis, 24, pp.1324~1328 (2015)
18. Selvik HA, "Cancerassociated stroke : the Bergen NORSTROKE study", Cerebrovasc Dis Extra, 5, pp.107~113 (2015)
19. Uemura J, "Acute stroke patients have occult malignancy more often than expected", Eur Neurol, 64, pp.140~144 (2010)
20. Conen D, "Risk of malignant cancer among women with newonset atrial fibrillation", JAMA Cardiol, 1, pp.389~396 (2016)
21. Plummer C, "Ischemic stroke and transient ischemic attack after head and neck radiotherapy : a review", Stroke, 42, pp.2410~2418 (2011)
22. Parikh NS, "Recurrent thromboembolic events after ischemic stroke in patients with primary brain tumors", J Stroke Cerebrovasc Dis, 26, pp.2396~2403 (2017)
23. Navi BB, "Multifocal stroke from tumor emboli", Arch Neurol, 66, pp.1174~1175 (2009)
24. Yamamoto A, "Characteristics of intravascular large B-cell lymphoma on cerebral MR imaging", AJNR Am J Neuroradiol, 33, pp.292~296 (2012)
25. Schwarzbach CJ, "Stroke and cancer : the importance of cancer-associated hypercoagulation as a possible stroke etiology", Stroke, 43, pp.3029~3034 (2012)
26. Gon Y, "Characteristics of cryptogenic stroke in cancer patients", Ann Clin Transl Neurol, 3, pp.280~287 (2016)
27. Lysov Z, "Procoagulant effects of lung cancer chemotherapy : impact on microparticles and cell-free DNA", Blood Coagul Fibrinolysis, 28, pp.72~82 (2017)
28. Semenza GL, "A new weapon for attacking tumor blood vessels", N Engl J Med, 358, pp.2066~2067 (2008)
29. Zuo PY, "Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab : a meta-analysis", PLoS One, 9, pp.e102484~ (2014)
30. Seok JM, "Coagulopathy and embolic signal in cancer patients with ischemic stroke", Ann Neurol, 68, pp.213~219 (2010)
31. Poppert H, "Embolic signals in unselected stroke patients : prevalence and diagnostic benefit", Stroke, 37, pp.2039~2043 (2006)
32. Singhal AB, "Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis : a diffusion-weighted magnetic resonance imaging study", Stroke, 33, pp.1267~1273 (2002)
33. Merkler AE, "Diagnostic yield of echocardiography in cancer patients with ischemic stroke", J Neurooncol, 123, pp.115~121 (2015)
34. Graus F, "Cerebrovascular complications in patients with cancer", Medicine(Baltimore), 64, pp.16~35 (1985)
35. Khorana AA, "Incidence and predictors of venous thromboembolism(VTE)among ambulatory high-risk cancer patients undergoing chemotherapy in the United States", Cancer, 119, pp.648~655 (2013)
36. Thompson CM, "Analysis of the autopsy records of 157 cases of carcinoma of the pancreas with particular reference to the incidence of thromboembolism", Am J Med Sci, 223, pp.469~478 (1952)
37. Iguchi Y, "Ischaemic stroke with malignancy may often be caused by paradoxical embolism", J Neurol Neurosurg Psychiatry, 77, pp.1336~1339 (2006)
38. Ay C, "Cancer-associated venous thromboembolism:burden, mechanisms, and management", Thromb Haemost, 117, pp.219~230 (2017)
39. Sousou T, "New insights into cancer-associated thrombosis", Arterioscler Thromb Vasc Biol, 29, pp.316~320 (2009)
40. Gomes M, "Risk assessment for thrombosis in cancer", Semin Thromb Hemost, 40, pp.319~324 (2014)
41. Pabinger I, "A clinical prediction model for cancer-associated venous thromboembolism : a development and validation study in two independent prospective cohorts", Lancet Haematol, 5, pp.e289~e298 (2018)
42. Ferroni P, "Validation of a machine learning approach for venous thromboembolism risk prediction in oncology", Dis Markers, 2017, pp.8781379~ (2017)
43. Simanek R, "High platelet count associated with venous thromboembolism in cancer patients : results from the Vienna Cancer and Thrombosis Study(CATS)", J Thromb Haemost, 8, pp.114~120 (2010)
44. Reitter EM, "Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment", J Thromb Haemost, 14, pp.294~305 (2016)
45. Gon Y, "Ischemic stroke in cancer patients treated with direct oral anticoagulants for venous thromboembolism", Thromb Res, 154, pp.16~18 (2017)
46. Bang OY, "Cancer cell-derived extracellular vesicles are associated with coagulopathy causing ischemic stroke via tissue factor-independent way : the OASIS-CANCER Study", PLoS One, 11, pp.e0159170~ (2016)
47. Chung JW, "Association of cancer cell type and extracellular vesicles with coagulopathy in patients with lung cancer and stroke", Stroke, 49, pp.1282~1285 (2018)
48. Brinkmann V, "Neutrophil extracellular traps kill bacteria", Science, 303, pp.1532~1535 (2004)
49. Bang OY, "Circulating DNAs, a marker of neutrophil extracellular traposis and cancer-related stroke: the OASIS-Cancer Study", Stroke, 50, pp.2944~2947 (2019)
50. Thålin C, "NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation", Thromb Res, 139, pp.56~64 (2016)
51. Leal AC, "Tumor-derived exosomes induce the formation of neutrophil extracellular traps : implications for the establishment of cancer-associated thrombosis", Sci Rep, 7, pp.6438~ (2017)
52. Daniel Addison, "Incidental Statin Use and the Risk of Stroke or Transient Ischemic Attack after Radiotherapy for Head and Neck Cancer", 대한뇌졸중영문학회지, 20(1), pp.71~79 (2018), 대한뇌졸중학회[DOI]
53. Grazioli S, "Cancer-associated ischemic stroke : a retrospective multicentre cohort study", Thromb Res, 165, pp.33~37 (2018)
54. Kim JM, "Clinical manifestation of cancer related stroke : retrospective casecontrol study", J Neurooncol, 111, pp.295~301 (2013)
55. Seok JM, "Clinical presentation and ischemic zone on MRI in cancer patients with acute ischemic stroke", Eur Neurol, 68, pp.368~376 (2012)
56. Kassubek R, "Identifying ischemic stroke associated with cancer : a multiple model derived from a case-control analysis", J Neurol, 264, pp.781~791 (2017)
57. 이미지, "Hypercoagulability and Mortality of Patients with Stroke and Active Cancer: The OASIS-CANCER Study", 대한뇌졸중영문학회지, 19(1), pp.77~87 (2017), 대한뇌졸중학회
58. Ito S, "Changes in serial D-dimer levels predict the prognoses of Trousseau’s syndrome patients", Front Neurol, 9, pp.528~ (2018)
59. Nam KW, "Ddimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer", Eur J Neurol, 24, pp.205~211 (2017)
60. Shin YW, "Predictors of survival for patients with cancer after cryptogenic stroke", J Neurooncol, 128, pp.277~284 (2016)
61. Bang OY, "Evaluation of cryptogenic stroke with advanced diagnostic techniques", Stroke, 45, pp.1186~1194 (2014)
62. Kearon C, "Antithrombotic therapy for VTE disease : CHEST guideline and expert panel report", Chest, 149, pp.315~352 (2016)
63. Lyman GH, "Venous thromboembolism prophylaxis and treatment in patients with cancer : American Society of Clinical Oncology clinical practice guideline update", J Clin Oncol, 31, pp.2189~2204 (2013)
64. Mandalà M, "Venous thromboembolism(VTE)in cancer patients : ESMO clinical recommendations for prevention and management", Thromb Res, 125(Suppl 2), pp.S117~S119 (2010)
65. Streiff MB, "NCCN guidelines insights: cancer-associated venous thromboembolic disease, version 2.2018", J Natl Compr Canc Netw, 16, pp.1289~1303 (2018)
66. Farge D, "International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer", Lancet Oncol, 17, pp.e452~e466 (2016)
67. Vedovati MC, "Direct oral anticoagulants in patients with VTE and cancer : a systematic review and meta-analysis", Chest, 147, pp.475~483 (2015)
68. Raskob GE, "Edoxaban for the treatment of cancer-associated venous thromboembolism", N Engl J Med, 378, pp.615~624 (2018)
69. Lyman GH, "Venous thromboembolism prophylaxis and treatment in patients with cancer : American Society of Clinical Oncology clinical practice guideline update 2014", J Clin Oncol, 33, pp.654~656 (2015)
70. Prandoni P, "Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis", Blood, 100, pp.3484~3488 (2002)
71. Posch F, "Treatment of venous thromboembolism in patients with cancer : a network meta-analysis comparing efficacy and safety of anticoagulants", Thromb Res, 136, pp.582~589 (2015)
72. Jang H, "Comparison of enoxaparin and warfarin for secondary prevention of cancer-associated stroke", J Oncol, 2015, pp.502089~ (2015)
73. Khorana AA, "Current practice patterns and patient persistence with anticoagulant treatments for cancer-associated thrombosis", Res Pract Thromb Haemost, 1, pp.14~22 (2017)
74. Navi BB, "Enoxaparin vs aspirin in patients with cancer and ischemic stroke : the TEACH pilot randomized clinical trial", JAMA Neurol, 75, pp.379~381 (2018)
75. Nam KW, "Treatment of cryptogenic stroke with active cancer with a new oral anticoagulant", J Stroke Cerebrovasc Dis, 26, pp.2976~2980 (2017)
76. Jung S, "Procedural and clinical outcomes of endovascular recanalization therapy in patients with cancer-related stroke", Interv Neuroradiol, 24, pp.520~528 (2018)
77. Park H, "Histological features of intracranial thrombi in stroke patients with cancer", Ann Neurol, 86, pp.143~149 (2019)
78. Duffy S, "Per-pass analysis of thrombus composition in patients with acute ischemic stroke undergoing mechanical thrombectomy", Stroke, 50, pp.1156~1163 (2019)
79. Ornello R, "Distribution and temporal trends from 1993 to 2015of ischemic stroke subtypes : a systematic review and metaanalysis", Stroke, 49, pp.814~819 (2018)
80. Van Middelaar T, "Effect of antihypertensive medication on cerebral small vessel disease : a systematic review and metaanalysis", Stroke, 49, pp.1531~1533 (2018)
81. Kimura H, "Pathologic study of intracranial large artery atherosclerosis in 7260 autopsy cases", J Stroke Cerebrovasc Dis, 26, pp.2821~2827 (2017)

관련 논문AI추천